Sheikh Khalifa Medical City
Abu Dhabi, United Arab Emirates
Dr. Shaden Abdelhadi is a Pediatric Dermatology Consultant, European Board and Arab Board Certified in Dermatology & Venereology, Belgian Board Certified in Pediatric Dermatology (including clinical training at Seattle Children’s Hospital, Seattle, USA). She holds the Belgian Board in Human Medical Genetics from the Belgian Society of Human Genetics BeSHG (including training at Guys & St. Thomas Genetic Skin Diseases Center in London, UK). Moreover, she is a Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin).
She is also the Director of the Arab Board, Emirati Board and ACGMEi accredited Dermatology Residency Program at Sheikh Khalifa Medical City, Abu Dhabi.
Dr. Shaden holds the distinction of being the first fully licensed Pediatric Dermatologist in Abu Dhabi.
She has been highly active in academics since 2012 including active teaching and supervision in her specialties in both Belgium and the UAE.
Dr. Shaden Abdelhadi is an Assistant Professor of Dermatology at College of Medicine and Health Sciences, Khalifa University in Abu Dhabi. In 2021, she was appointed as a founding committee member and section chair, National Institute of Health Specialties (NIHS) for the Emirati Board of Dermatology.
Moreover, she is the founder and head of the Multidisciplinary Epidermolysis Bullosa Center at SKMC.
Additionally, she is a Fellow of the American Academy of Dermatology (FAAD), the European Academy of Dermatology and Venereology (FEADV) and the European Society of Pediatric Dermatology (FESPD).
Dr. Shaden is a Member of the Editorial Board of the Dermatologic Therapy, a John Wiley & Sons Ltd. journal.